Evaluation of microvasculopathy using dual‐energy computed tomography in patients with chronic thromboembolic pulmonary hypertension
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by Wiley in Pulmonary Circulation
- Vol. 11 (1) , 1-9
Abstract
The existence of microvasculopathy in patients with chronic thromboembolic pulmonary hypertension has been suggested. Recently, dual‐energy computed tomography has been used to produce a sensitive iodine distribution map in lung fields to indicate microvasculopathy according to poor subpleural perfusion. Our aim was to evaluate the impact of microvasculopathy on pathophysiology in chronic thromboembolic pulmonary hypertension. According to the extent of poor subpleural perfusion, ninety‐three interventional treatment‐naïve patients were divided into poorly perfused (n = 49) or normally perfused group (n = 44). We assessed cardiopulmonary exercise test, right heart catheterization, and dual‐energy computed tomography parameters for quantitative evaluation of lung perfusion of blood volume score. Lung perfusion of blood volume score in normally perfused group was significantly inversely correlated with pulmonary vascular resistance (pulmonary vascular resistance = 6816.1 × lung perfusion of blood volume score−0.793, R2 = 0.225, p < 0.01), but lung perfusion of blood volume score in poorly perfused group was not. Poorly perfused group had higher pulmonary vascular resistance (879 ± 409 dynes‐s/cm5 vs. 574 ± 279 dynes‐s/cm5, p < 0.01) and lower lung perfusion of blood volume score (22.1 ± 5.4 vs. 26.4 ± 6.6, p < 0.01) and % diffusing capacity for carbon monoxide divided by the alveolar volume (59.9 ± 15.4% vs. 78.8 ± 14.2%, p < 0.01). Perfusion of blood volume score in the normally perfused group showed an inverse correlation with pulmonary vascular resistance; however, that in poorly perfused group did not. Microvasculopathy might contribute to severe hemodynamics, apart from pulmonary vascular obstruction. In our experience, more than half of treatment‐naïve chronic thromboembolic pulmonary hypertension patients have microvasculopathy.Keywords
This publication has 19 references indexed in Scilit:
- Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculatureEuropean Respiratory Journal, 2014
- Chronic thromboembolic pulmonary hypertension: animal modelsEuropean Respiratory Journal, 2013
- Subpleural Perfusion as a Predictor for a Poor Surgical Outcome in Chronic Thromboembolic Pulmonary HypertensionChest, 2012
- Dual Energy CT in Clinical PracticeMedical Physics, 2011
- Lung Perfused Blood Volume Images With Dual-Energy Computed Tomography for Chronic Thromboembolic Pulmonary HypertensionJournal of Computer Assisted Tomography, 2011
- Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiologyEuropean Respiratory Review, 2010
- Chronic Thromboembolic Pulmonary HypertensionCirculation, 2006
- Preoperative Partitioning of Pulmonary Vascular Resistance Correlates With Early Outcome After Thromboendarterectomy for Chronic Thromboembolic Pulmonary HypertensionCirculation, 2004
- Comparison of bronchopulmonary collaterals and collateral blood flow in patients with chronic thromboembolic and primary pulmonary hypertension.Heart, 1997
- Pulmonary Vascular Lesions Occurring in Patients With Chronic Major Vessel Thromboembolic Pulmonary HypertensionChest, 1993